Kamlesh Patel
About Kamlesh Patel
Kamlesh Patel serves as the Vice President of Pharmaceutical Sciences at Brii Biosciences, where he has worked since 2020. He has extensive experience in pharmaceutical formulation development and regulatory interactions, having previously held a long-term position at GSK.
Work at Brii Biosciences
Kamlesh Patel serves as the Vice President of Pharmaceutical Sciences at Brii Biosciences since 2020. In this role, he manages a team of approximately 45 staff members focused on the development of pharmaceutical formulations. Patel has provided strategic direction for the development of nanomilled formulations aimed at improving the solubility of poorly soluble compounds. He has also driven the implementation of Quality by Design concepts in product development, enhancing the overall efficiency and effectiveness of the processes at Brii Biosciences.
Education and Expertise
Kamlesh Patel has a robust educational background in pharmaceutical sciences. He earned a Bachelor of Pharmacy (B Pharm) from Gujarat University. He furthered his studies at The University of Kansas, where he obtained a PhD in Pharmaceutical Chemistry from 1985 to 1989. Additionally, he completed a Master of Science (MSc) in Pharmaceutical Technologies at the University of London from 1981 to 1983. This extensive education underpins his expertise in pharmaceutical formulation and development.
Background
Before joining Brii Biosciences, Kamlesh Patel worked at GlaxoSmithKline (GSK) for 30 years, from 1989 to 2019. During his tenure there, he held the position of Group Director in Drug Product Design and Development, focusing on sterile product development and supply. His experience at GSK provided him with a strong foundation in pharmaceutical product development and regulatory interactions, which he has continued to leverage in his current role.
Regulatory Experience
In his current position at Brii Biosciences, Kamlesh Patel has supported the preparation of regulatory documents and facilitated interactions with the FDA and other regulatory agencies. His experience in regulatory affairs is critical for ensuring compliance and successful product approvals, which are essential components of the pharmaceutical development process.
Key Contributions
Kamlesh Patel has played a significant role in the transfer of assets to GSK following in-licensing agreements. His contributions in this area demonstrate his ability to navigate complex business arrangements and support strategic partnerships within the pharmaceutical industry.